Send email to which list:

Your new issue of Regulated Times is here!
Cigna Healthcare

The Regulated Times

September 9, 2025

Vol 5. Issue 4

Federal Policymakers Tour Facilities in Missouri, Pennsylvania, and Tennessee

September 9, 2025

EGWP marketplace medicaid Medicare

Federal policymakers recently visited Express Scripts and Accredo sites across the country to get a firsthand look at how our employees work every day to improve the health and vitality [...]

Read more >

White House Issues Pharma Directive on MFN Drug Pricing

September 9, 2025

EGWP marketplace medicaid Medicare

On July 31, President Trump issued letters to 17 drug manufacturers warning that if the companies did not take certain steps within 60 days to lower prescription drug prices, the [...]

Read more >

PCMA Highlights Recent Pro PBM Comments

September 9, 2025

EGWP marketplace medicaid Medicare

PCMA recently highlighted several op-eds from policy analysts and economists who have spoken out on the value of PBMs. Satya Marar, visiting postgraduate fellow at the Mercatus Center at George [...]

Read more >

ACAP Webinar Replay: Weighing the Costs of GLP-1s in Medicaid

September 9, 2025

medicaid

Missed our recent webinar with Association for Community Affiliated Plans (ACAP)? You can now access the recording to learn about key GLP-1 topics including utilization and spending trends among youth [...]

Read more >

News

US-EU Announces Trade Framework Agreement


Trump Signs EO to Strengthen Pharmaceutical Supply Chain


Federal Court Postpones Effective Date of Several Provisions in ACA Marketplace Integrity Rule


HHS Announces 340B Drug Rebate Pilot Program


Wisconsin’s PBM Bill Amended, Advances from Senate Health Committee


Colorado Lawmakers Adjourn Special Session; Raise Revenue


Pennsylvania Lawmaker Seeks Support for Vertical Integration Bill


California Insurers and Business Groups Push Affordability Campaign


Insights

CASMB Sends Letter to Administration Opposing Private Equity Firm’s IDR Application

New Report Finds Pharma-Backed Provision in Tax Law Likely to Cost Far More than Previously Estimated

Events

ACAP Webinar Replay: Weighing the Costs of GLP-1s in Medicaid